Skip to main content
BioNTech SE (ETR:22UA)
Germany flag Germany · Delayed Price · Currency is EUR
82.60
-0.30 (-0.36%)
At close: Dec 5, 2025

BioNTech SE Revenue

BioNTech SE had revenue of 1.52B EUR in the quarter ending September 30, 2025, with 22.02% growth. This brings the company's revenue in the last twelve months to 3.15B, up 3.70% year-over-year. In the year 2024, BioNTech SE had annual revenue of 2.75B, down -27.96%.

Revenue (ttm)
3.15B
Revenue Growth
+3.70%
P/S Ratio
6.31
Revenue / Employee
465.52K
Employees
6,772
Market Cap
19.89B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20242.75B-1.07B-27.96%
Dec 31, 20233.82B-13.49B-77.94%
Dec 31, 202217.31B-1.67B-8.78%
Dec 31, 202118.98B18.49B3,834.63%
Dec 31, 2020482.30M373.70M344.11%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Merck KGaA 21.27B
Siemens Healthineers AG 23.38B
Bayer Aktiengesellschaft 45.87B
Fresenius SE & Co. KGaA 22.45B
Sartorius Aktiengesellschaft 3.52B
Fresenius Medical Care AG 19.64B
Carl Zeiss Meditec AG 2.18B
Fielmann Group AG 2.42B
Revenue Rankings

BioNTech SE News

More News